107 related articles for article (PubMed ID: 35780818)
41. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
42. Cultural factors associated with racial disparities in lung cancer care.
Lin JJ; Mhango G; Wall MM; Lurslurchachai L; Bond KT; Nelson JE; Berman AR; Salazar-Schicchi J; Powell C; Keller SM; Halm EA; Leventhal H; Wisnivesky JP
Ann Am Thorac Soc; 2014 May; 11(4):489-95. PubMed ID: 24701981
[TBL] [Abstract][Full Text] [Related]
43. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.
Sineshaw HM; Ng K; Flanders WD; Brawley OW; Jemal A
Gastroenterology; 2018 Mar; 154(4):906-915.e7. PubMed ID: 29146523
[TBL] [Abstract][Full Text] [Related]
44. Disparities in Lung Cancer Treatment.
Harrison S; Judd J; Chin S; Ragin C
Curr Oncol Rep; 2022 Feb; 24(2):241-248. PubMed ID: 35080738
[TBL] [Abstract][Full Text] [Related]
45. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.
Mateen FJ; Jatoi A; Lineberry TW; Aranguren D; Creagan ET; Croghan GA; Jett JR; Marks RS; Molina JR; Richardson RL
Psychooncology; 2008 Jul; 17(7):721-5. PubMed ID: 18050362
[TBL] [Abstract][Full Text] [Related]
46. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
47. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
Landrum MB; Keating NL; Lamont EB; Bozeman SR; McNeil BJ
Cancer; 2012 Jul; 118(13):3345-55. PubMed ID: 22072536
[TBL] [Abstract][Full Text] [Related]
48. Delays in the diagnosis and treatment of non-small-cell lung cancer.
Sulu E; Tasolar O; Berk Takir H; Yagci Tuncer L; Karakurt Z; Yilmaz A
Tumori; 2011; 97(6):693-7. PubMed ID: 22322833
[TBL] [Abstract][Full Text] [Related]
49. The Patient Perspective on Lung Cancer Screening and Health Disparities.
Borondy Kitts AK
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):601-606. PubMed ID: 30947894
[TBL] [Abstract][Full Text] [Related]
50. Important prognostic factors for lung cancer in tobacco predominant Eastern North Carolina: study based on a single cancer registry.
Biswas T; Walker P; Podder T; Rosenman J; Efird J
Lung Cancer; 2014 May; 84(2):116-20. PubMed ID: 24602393
[TBL] [Abstract][Full Text] [Related]
51. Lung Cancer in Nonelderly Patients: Facility and Patient Characteristics Associated With Not Receiving Treatment.
Nardi EA; Sun CL; Robert F; Wolfson JA
J Natl Compr Canc Netw; 2019 Aug; 17(8):931-939. PubMed ID: 31390587
[TBL] [Abstract][Full Text] [Related]
52. Delays for diagnosis and treatment of lung cancers: a systematic review.
Vinas F; Ben Hassen I; Jabot L; Monnet I; Chouaid C
Clin Respir J; 2016 May; 10(3):267-71. PubMed ID: 25308518
[TBL] [Abstract][Full Text] [Related]
53. Does access to private healthcare influence potential lung cancer cure rates?
John TJ; Plekker D; Irusen EM; Koegelenberg CFN
S Afr Med J; 2017 Jul; 107(8):687-690. PubMed ID: 28809615
[TBL] [Abstract][Full Text] [Related]
54. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.
Palazzo LL; Sheehan DF; Tramontano AC; Kong CY
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):926-934. PubMed ID: 30787053
[TBL] [Abstract][Full Text] [Related]
55. Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.
Goksu SY; Ozer M; Kazmi SMA; Aguilera TA; Ahn C; Hsiehchen D; Sanjeevaiah A; Maxwell MC; Beg MS; Sanford NN
Am J Clin Oncol; 2020 Nov; 43(11):762-769. PubMed ID: 32804778
[TBL] [Abstract][Full Text] [Related]
56. Waiting times in early-stage non-small cell lung cancer (NSCLC).
Saint-Jacques N; Rayson D; Al-Fayea T; Virik K; Morzycki W; Younis T
J Thorac Oncol; 2008 Aug; 3(8):865-70. PubMed ID: 18670304
[TBL] [Abstract][Full Text] [Related]
57. Treatment of stage I non-small cell lung cancer: What's trending?
McMurry TL; Shah PM; Samson P; Robinson CG; Kozower BD
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1080-1087. PubMed ID: 28476421
[TBL] [Abstract][Full Text] [Related]
58. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
Kommalapati A; Tella SH; Appiah AK; Smith L; Ganti AK
J Natl Compr Canc Netw; 2019 Mar; 17(3):229-236. PubMed ID: 30865920
[TBL] [Abstract][Full Text] [Related]
59. Predictors of treatment initiation and mapping the cancer diagnostic pathway: A retrospective observational cohort study of patients with metastatic non-small cell lung cancer.
Sharman Moser S; Yaari S; Urban D; Apter L; Passwell N; Teper G; Chodick G; Siegelmann-Danieli N
Cancer Epidemiol; 2022 Aug; 79():102156. PubMed ID: 35594797
[TBL] [Abstract][Full Text] [Related]
60. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival.
Atkins GT; Kim T; Munson J
Ann Am Thorac Soc; 2017 Mar; 14(3):403-411. PubMed ID: 28118039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
